Inhibition of Membrane-Bound Methane Monooxygenase and Ammonia Monooxygenase by Diphenyliodonium: Implications for Electron Transfer by Shiemke, A. K. et al.
Faculty Scholarship
2004
Inhibition of Membrane-Bound Methane
Monooxygenase and Ammonia Monooxygenase





Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications
This Article is brought to you for free and open access by The Research Repository @ WVU. It has been accepted for inclusion in Faculty Scholarship
by an authorized administrator of The Research Repository @ WVU. For more information, please contact ian.harmon@mail.wvu.edu.
Digital Commons Citation
Shiemke, A. K.; Arp, D. J.; and Sayavedra-Soto, L. A., "Inhibition of Membrane-Bound Methane Monooxygenase and Ammonia
Monooxygenase by Diphenyliodonium: Implications for Electron Transfer" (2004). Faculty Scholarship. 196.
https://researchrepository.wvu.edu/faculty_publications/196
JOURNAL OF BACTERIOLOGY, Feb. 2004, p. 928–937 Vol. 186, No. 4
0021-9193/04/$08.000 DOI: 10.1128/JB.186.4.928–937.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Inhibition of Membrane-Bound Methane Monooxygenase and
Ammonia Monooxygenase by Diphenyliodonium:
Implications for Electron Transfer
Andrew K. Shiemke,1* Daniel J. Arp,2 and Luis A. Sayavedra-Soto2
Department of Biochemistry and Molecular Pharmacology, Robert C. Byrd Health Sciences Center, West Virginia
University School of Medicine, Morgantown, West Virginia 26506-9142,1 and Department of Botany
and Plant Pathology, Oregon State University, Corvallis, Oregon 97331-29022
Received 16 September 2003/Accepted 7 November 2003
Diphenyliodonium (DPI) is known to irreversibly inactivate flavoproteins. We have found that DPI inhibits
both membrane-bound methane monooxygenase (pMMO) from Methylococcus capsulatus and ammonia mono-
oxygenase (AMO) of Nitrosomonas europaea. The effect of DPI on NADH-dependent pMMO activity in vitro is
ascribed to inactivation of NDH-2, a flavoprotein which we proposed catalyzes reduction of the quinone pool
by NADH. DPI is a potent inhibitor of type 2 NADH:quinone oxidoreductase (NDH-2), with 50% inhibition
occurring at 5 M. Inhibition of NDH-2 is irreversible and requires NADH. Inhibition of NADH-dependent
pMMO activity by DPI in vitro is concomitant with inhibition of NDH-2, consistent with our proposal that
NDH-2 mediates reduction of pMMO. Unexpectedly, DPI also inhibits pMMO activity driven by exogenous
hydroquinols, but with 100 M DPI required to achieve 50% inhibition. Similar concentrations of DPI are
required to inhibit formate-, formaldehyde-, and hydroquinol-driven pMMO activities in whole cells. The
pMMO activity in DPI-treated cells greatly exceeds the activity of NDH-2 or pMMO in membranes isolated
from those cells, suggesting that electron transfer from formate to pMMO in vivo can occur independent of
NADH and NDH-2. AMO activity, which is known to be independent of NADH, is affected by DPI in a manner
analogous to pMMO in vivo: 100 M is required for 50% inhibition regardless of the nature of the reducing
agent. DPI does not affect hydroxylamine oxidoreductase activity and does not require AMO turnover to exert
its inhibitory effect. Implications of these data for the electron transfer pathway from the quinone pool to
pMMO and AMO are discussed.
Ammonia monooxygenase (AMO) and the membrane-
bound form of methane monooxygenase (pMMO) are two of
the three members of a novel family of membrane-bound
monooxygenases capable of oxidizing small hydrocarbons (3,
33). These two enzymes are similar in their putative subunit
composition, inhibitor profiles, and the DNA sequence of the
genes encoding the subunits (19, 20, 22). The membrane-
bound butane monooxygenase from Nocardioides sp. strain
CF8 was recently identified as the third member of this class of
enzymes, sharing many of the characteristics of pMMO and
AMO (18). These enzymes are known to require copper, be-
cause inhibition by metal chelators is reversed only by addition
of copper (14, 17). In addition, all three are irreversibly inhib-
ited by acetylene, and when radiolabeled acetylene is used, a
27-kDa peptide is specifically labeled (5, 18, 26, 37).
Enzymes of this class can oxidize small alkanes and haloge-
nated solvents, hence their potential application in bioreme-
diation (9, 25, 29, 45). Although there are other enzymes that
are able to oxidize small alkanes (32, 46, 47), they are distinct
in structure and properties from AMO and pMMO. These two
enzymes thus represent a novel mechanism for alkane oxida-
tion, one that has yet to be elucidated due to the difficulty in
isolating pure samples of either enzyme with high activity (4,
17, 28, 31, 49, 51).
AMO and pMMO initiate oxidative metabolism of NH3 and
CH4 in nitrifying and methanotrophic bacteria, respectively
(3, 19). Both types of bacteria obtain energy solely from the
subsequent oxidation of the products of the monooxygenase
reaction. In methanotrophs, energy needs are satisfied by the
oxidation of methanol to CO2 by periplasmic and cytosolic
dehydrogenases specific for methanol, formaldehyde, and for-
mate (1). In nitrifying bacteria, the 4-electron oxidation of
hydroxylamine to nitrite by hydroxylamine oxidase (HAO) pro-
vides reductant for ammonia oxidation and all other cellular
processes (8).
AMO and pMMO are notoriously refractory to purification.
AMO has not been purified to homogeneity with activity, and
although several laboratories have reported purification of
active pMMO (4, 31, 34, 49, 51), the specific activity of the
purified enzyme is a small fraction of the activity in vivo.
Disruption of the physiological electron transfer pathways to
AMO and pMMO may be in part responsible for the deterio-
ration of activity in vitro (40, 41). These pathways are poorly
characterized (1, 48), and thus, the reducing agents used in
vitro may not be physiologically relevant, resulting in inefficient
electron transfer to their active sites.
NADH generated from oxidation of formaldehyde and for-
mate is believed to be the source of reducing equivalents for
methane oxidation (2). It is well established that NADH di-
rectly reduces the soluble form of methane monooxygenase
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(sMMO), mediated by an iron-sulfur flavoprotein reductase
(32). NADH is also the optimal reductant for pMMO in iso-
lated membrane fractions (42). However, we and others have
reported that NADH is ineffective with detergent-solubilized
or purified pMMO, which can only be reduced by exogenous
hydroquinols, such as duroquinol (4, 40, 41, 51). We recently
reported isolation of a 36-kDa flavoprotein from membranes
of Methylococcus capsulatus that has characteristics of a type 2
NADH:quinone oxidoreductase (NDH-2) and suggested that
it mediates electron transfer to pMMO in conjunction with the
endogenous quinone pool (solid lines in Fig. 1A) (13). Support
for this suggestion comes from a recent report in which high
pMMO activity was sustained by NADH and exogenous qui-
nones only after addition of purified NDH-2 (11). Further-
more, the specific activity in the presence of duroquinone,
NADH, and NDH-2 was 40% greater than that with duro-
quinol alone (11). However, Chan and coworkers recently re-
ported pMMO activity in detergent-solubilized membranes
with either NADH or duroquinol as the reductant but 10-fold
greater specific activity with the quinol (49). Their purified
pMMO samples had similar specific activity with either NADH
or duroquinol as the reductant (49), but 4- to 10-fold lower
than reported by others (4, 11). Clearly, more work is necessary
to elucidate electron transfer to pMMO both in vivo and in
vitro.
In the present study we used diphenyliodonium (DPI) to
further investigate the electron transfer pathways to pMMO
and AMO. DPI and other diaryl-iodonium compounds irre-
versibly inactivate many redox-active proteins, primarily fla-
voproteins (10, 15, 35, 36, 43), but DPI may also react with
some low-potential b-type cytochromes and quinoproteins (6,
16). The proposed mechanism for DPI inactivation of fla-
voproteins (10, 35) is shown in Fig. 2: DPI accepts one electron
from the fully reduced flavin, generating a DPI free radical and
the flavin semiquinone. Spontaneous cleavage of the DPI rad-
ical yields a benzene radical which combines with the flavin
semiquinone, resulting in covalent modification of the cofactor
and irreversible inactivation of its redox cycle. DPI is thought
to inactivate other redox-active proteins by a similar mecha-
nism involving reduction of DPI and radical recombination
with the cofactor (16).
In this work we show that DPI irreversibly inactivated the
NDH-2 from M. capsulatus, leading to irreversible inhibition of
NADH-dependent pMMO activity in vitro, as expected (solid
lines in Fig. 1A). However, DPI inhibited pMMO activity in
vitro even when reducing equivalents were provided down-
stream of NDH-2 by hydroquinols, suggesting that a second
DPI-sensitive protein is required for reduction of pMMO. We
show that DPI also inhibited pMMO activity in whole cells in
a manner that is apparently independent of NDH-2 (dashed
lines in Fig. 1A). DPI irreversibly inhibited the activity of
AMO in whole cells of Nitrosomonas europaea as well.
Electron transfer to AMO is independent of NADH (Fig.
1B) (22, 48), so the site of DPI inhibition cannot be analogous
to the NDH-2 of M. capsulatus. AMO is inhibited by DPI
whether reducing equivalents are donated through HAO by
hydroxylamine or hydrazine or at the level of the quinone pool
by duroquinol. Furthermore, DPI does not affect electron
transfer from HAO to the terminal oxidase and does not have
the characteristics of a mechanism-based inhibitor of AMO.
Thus, we propose that DPI acts to interrupt electron transfer
from the quinone pool to AMO (Fig. 1B), perhaps by irrevers-
FIG. 1. Proposed electron transfer pathways to pMMO in M. capsulatus (A) and to AMO in N. europaea (B). The solid lines in A depict the
pathway proposed in reference 13, and the dashed lines represent the NADH-independent pathway we propose for in vivo reduction of pMMO
based on the data presented in this work. The pathway depicted in part B is adapted from reference 48. In both pathways, proposed sites of
inhibition by DPI are indicated by a vertical bar.
FIG. 2. Proposed mechanism for inhibition of flavoproteins by
DPI, adapted from references 10 and 34. Fl represents the protein-
bound flavin cofactor.
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ibly binding to a site analogous to the NDH-2-independent site
in M. capsulatus.
MATERIALS AND METHODS
Growth of bacteria. M. capsulatus (strain Bath) was maintained at 45°C on
1.8% agar plates in an atmosphere of 30% methane in air, and cultures in
liquid medium were grown at 45°C in NMS medium supplemented with phos-
phate buffer, vitamins, and copper, as described in previous reports (13, 40). M.
capsulatus was harvested at late log phase by centrifugation for 10 min at 8,000
 g from either 500-ml batch cultures in 2-liter flasks or 10-liter batch cultures
grown in a 14-liter fermenter according to published procedures (40). Cells were
washed one to three times in a volume of 10 mM piperazine-N,N-bis(2-ethane-
sulfonic acid) (PIPES, pH 7.2) equal to 2% of the culture volume. The washed
cells were suspended in 50 mM PIPES, pH 7.2, in a final volume that was 0.5%
of the culture volume. Cells were stored at 4°C under argon and typically used
within 5 days of harvesting.
N. europaea was grown in batch cultures at 30°C with shaking in a minimal
medium, as previously described (17, 29). The cells were harvested by centrifu-
gation at 8,000  g from 1.5-liter cultures at late log phase. Cells were washed
three times with 50 mM phosphate, pH 8.0, and suspended in the same buffer at
a volume equivalent to 0.1% of the culture volume. Cells were stored at 4°C and
used within 3 days.
Membrane isolation. Similar procedures were used to isolate membrane frac-
tions from M. capsulatus and N. europaea. Cells were suspended in buffer (50 mM
PIPES, pH 7.2, for M. capsulatus and 50 mM phosphate, pH 8.0, for N. europaea)
at 15 to 30 mg/ml total protein concentration. Both types of cell suspension were
supplemented with 1 mM phenylmethylsulfonyl fluoride and 200 M Cu(SO4),
and N. europaea also contained 10 mg of bovine serum albumin per ml. Cell
suspensions were passed three times through a French press cell at 18,000 to
20,000 lb/in2. The cell lysate was centrifuged at 8,000  g for 10 min to remove
unbroken cells. Sufficient NaCl was added to the supernatant to bring the con-
centration to 1 M, to facilitate release of peripheral proteins from the membrane.
The supernatant was then centrifuged at 106,000  g for 60 to 90 min. The pellet
was suspended with a Dounce homogenizer in 50 mM buffer containing 100 M
Cu(SO4), centrifuged again at 106,000  g for 60 min, and suspended in a volume
of 50 mM buffer equivalent to half of the original volume of cell suspension.
Membrane samples were stored at 4°C and used for experiments within 48 h of
isolation.
Detergent solubilization of pMMO and NDH-2 and purification of NDH-2.
NDH-2 and pMMO were solubilized from the M. capsulatus membrane fraction
by addition of a 20% (wt/vol) stock solution of lauryl maltoside. The detergent
was added with vortexing to a final detergent-to-protein ratio of 0.9 (wt/wt). The
sample was incubated on ice for 30 to 45 min with frequent vortexing, then
centrifuged at 106,000  g for 60 min. The supernatant was used immediately for
pMMO or NDH assays or NDH-2 isolation. The NDH-2 was purified by column
chromatography, and purity was determined by silver-stained sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels, as described pre-
viously (13). The purified protein was stored at 4°C and used for experiments
within 1 week. No loss of activity was observed over this time.
Enzyme assays. The activity of pMMO was assayed by measuring the rate of
propylene oxidation, as previously described (12, 13). Propylene oxide was mea-
sured by injecting either 2 l of solution or 100 l of headspace into a SRI-8610
gas chromatograph (SRI Instruments, Torrance, Calif.) equipped with an Rtx-1
capillary column (30 m by 0.53 mm; Restek Corp., Bellefonte, Pa.) and flame
ionization detector. The concentration of propylene oxide was determined from
the integrated peak area relative to a standard curve. Formate, formaldehyde, or
duroquinol was used as the reductant for whole-cell assays, as indicated in the
figure legends, whereas NADH or hydroquinols were used to assay membrane
and detergent-solubilized samples, according to previously published methods
(13, 40).
AMO activity was determined from the rate of ethylene oxidation or the rate
of ammonia-dependent oxygen uptake (27, 38). In the former assay, 1 ml of
sample was incubated at 30°C for 3 min in a septum-sealed 6-ml vial. The assay
was initiated by adding 5 to 10 l of reductant (hydrazine, hydroxylamine, or
duroquinol) from a concentrated stock solution, followed by 3 ml of ethylene.
Ethylene oxide concentration was measured by injecting 100 l of headspace into
a Shimadzu model GC-8A gas chromatograph (Shimadzu Corp., Kyoto, Japan)
equipped with a Porapak-Q column (0.3 cm inner diameter by 40 cm long;
Waters Associates, Framingham, Mass.) and flame-ionization detector and ref-
erenced to a standard curve. The oxygen uptake assay was performed with a
polarographic oxygen electrode (Yellow Springs Instruments) and a cell main-
tained at 30°C. The assay was initiated by adding 6 l of 1 M (NH4)2SO4 and the
change in percent oxygen saturation over time was recorded on a chart recorder.
The rate of oxygen uptake in micromoles per minute was calculated based on a
concentration of 230 M O2 in air-saturated buffer (44).
HAO activity was also measured polarographically as the rate of hydroxy-
lamine-dependent oxygen uptake (30). Samples were prepared as above, and the
assay was initiated by adding 10 l of a 0.25 M solution of hydroxylamine. To
determine AMO and HAO activity on the same sample, AMO activity was
measured as above, but when the oxygen concentration reached 40% satura-
tion, 10 l of 100 mM allylthiourea was added to completely inhibit O2 uptake
by AMO. HAO activity was then measured by adding hydroxylamine, as de-
scribed above.
NDH activity of membrane fractions and purified NDH-2 was measured as
either the rate of quinone reduction in the presence of NADH or the rate of
quinone-dependent NADH oxidation, according to methods described previ-
ously (13). The rate of absorbance change was measured with an Aminco DW-
2000 spectrometer, equipped with a stirred, thermostatted cell holder.
In some cases the effect of DPI on enzyme activity was determined by per-
forming the assay in the presence of the inhibitor (as in Fig. 3 and 5A), which was
prepared as a 10 mM stock solution in aqueous buffer. In these assays the
presence of DPI and reductant caused the enzyme activity to decrease steadily
during the assay. Therefore, activity was determined from the initial linear
portion of the assay: the first 60 s for NDH-2 and the first 3 min for pMMO. In
all other cases the cells or membranes were incubated with DPI, followed by
extensive washing to remove the unreacted inhibitor prior to performing the
assays, as described above.
Protein concentrations were determined with the bicinchoninic acid assay with
reagents from Pierce Chemical Corp. and bovine serum albumin as the standard.
Whole cells and membrane fractions were digested in 1.0 M NaOH at 90°C for
10 min prior to the protein assay.
Materials. Ethanol was removed from NADH by two cycles of dissolving it in
water and lyophilizing to dryness. Quinones and hydroquinols were prepared as
concentrated stock solutions (50 mM) in ethanol or dimethyl sulfoxide. The
dimethyl sulfoxide solutions were added directly to the protein samples. The
quinones in ethanol solution were placed in a vial and dried under vacuum to
remove the solvent to prevent interference with GC detection of assay products.
The protein sample was added to this vial and vortexed vigorously prior to
addition of the substrate.
Hydroquinols were prepared by reducing the quinone with zinc dust in either
ethanol or dimethyl sulfoxide containing 50 mM HCl. For a typical reaction, 1 ml
of quinone (50 mM in ethanol or dimethyl sulfoxide) was placed in a 1.5-ml
microcentrifuge tube, and 20 mg of Zn dust was added, followed by 50 l of 1.0
M HCl. This sample was shaken at room temperature until it became colorless.
The excess Zn dust was removed by centrifugation at 14,000  g for 3 min.
Water-soluble contaminants (principally Zn2) were removed by adding the
supernatant to 15 ml of 10 mM HCl. The hydroquinol formed a white precipitate
that was collected by centrifugation, washed twice with 10 mM aqueous HCl, and
dissolved in 0.5 ml of ethanol or dimethyl sulfoxide containing 10 mM HCl.
The stock solutions of hydroquinol were stored at 80°C to prevent oxidation.
The concentrations of quinone and hydroquinol stock solutions were determined
spectrophotometrically, with published extinction coefficients (40). All other
materials were used as supplied by the manufacturer without further purification.
RESULTS
DPI inhibition of NDH-2. NDH-2 from M. capsulatus cata-
lyzes NADH-dependent quinone reduction (13). DPI was a
potent inhibitor of NADH-dependent quinone reduction in M.
capsulatus membranes (Fig. 3). This inhibition required reduc-
tion by NADH; longer incubation of the membrane samples
with DPI and NADH (0, 3, and 8 min) resulted in a dramatic
increase in the extent of inhibition (Fig. 3). In contrast, little or
no effect on quinone reductase activity was observed after
incubating membranes for 8 min with DPI in the absence of
NADH (Fig. 3). Incubation of purified NDH-2 for 45 s with 10
M DPI and 200 M NADH results in 97% inhibition of the
rate of duroquinone-dependent NADH oxidation (Fig. 3, in-
set). The effect of DPI on NDH-2 activity was irreversible;
overnight dialysis of purified, DPI-treated NDH-2 resulted in
no change in the extent of inhibition (data not shown), and
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extensive washing of DPI-treated membranes did not reverse
the inhibitory effect of DPI (Fig. 4).
DPI inhibition of pMMO. To determine if DPI affects
pMMO activity, membrane samples from M. capsulatus were
incubated with increasing concentrations of DPI in the pres-
ence of 2 mM NADH. The results of this titration with DPI
(Fig. 4) demonstrated that NADH-driven pMMO activity was
extensively inhibited by DPI. Only 8% of the original pMMO
activity remained after treatment with 50 M DPI. Measure-
ment of NDH-2 activity in the same DPI-treated membrane
samples demonstrated a comparable response to DPI, such
that 50% inhibition was observed at 2 M and 5 M for
NDH-2 and pMMO activities, respectively (Fig. 4). In this
experiment, the activities of both NDH-2 and pMMO were
measured after the membranes were washed to remove unre-
acted DPI and NADH, suggesting that the effect of DPI is
irreversible. When NADH was absent from the incubation
with DPI, little or no inhibition of either NDH-2 or pMMO
activity was observed (data not shown).
As was observed for NDH-2 activity, the extent of DPI
inhibition of pMMO activity depended on the length of the
incubation with NADH (Table 1). In this experiment, the effect
of DPI was determined without washing the membranes.
Therefore, significant inhibition is observed for the time zero
incubation, since DPI and NADH are present throughout the
assay (Table 1).
Some DPI-sensitive enzymes are protected from inactivation
in the presence of an electron acceptor. For example, increas-
ing concentrations of cytochrome c resulted in reduced sensi-
tivity of cytochrome P450 reductase to DPI, ascribed to de-
creased availability of the reduced flavin to DPI. Decyl-
plastoquinone (PQ) is an effective electron acceptor for NDH-
2 (13), and therefore we examined the ability of PQ to protect
pMMO from DPI inhibition. Increasing concentrations of PQ
FIG. 3. Inhibition of NDH-2 from M. capsulatus by DPI is enhanced by incubation with NADH. Membrane samples were incubated at 25°C with
0 to 25 M DPI and 1 mM NADH for 0, 3, or 8 min. The assay was initiated by addition of 1 mM 2,3-dimethoxy-5-methyl-1,4-benzoquinone (Q-
zero), and the rate of Q-zero reduction was monitored by the decrease in absorbance at 410 nm during the initial 45 s of the assay. As a control,
membrane samples were incubated for 8 min with 0 to 25 M DPI in the absence of NADH before initiating the assay. Each data point is reported
as the mean value  standard deviation of three or four measurements. The inset shows the effect of 10 M DPI on the activity of pure NDH-2.
DPI and 0.2 mM NADH were added to the enzyme sample at time zero and incubated at 25°C for 45 s before initiating NDH-2-catalyzed NADH
oxidation with 0.25 mM Q-zero.
FIG. 4. DPI inhibition of pMMO and NDH-2 in membranes from
M. capsulatus. Membrane samples were incubated for 3 min at 45°C
with 2 mM NADH and 0 to 50 M DPI and washed three times by
centrifugation before measuring pMMO and NDH activity. The
pMMO activity was measured as the rate of NADH-driven propylene
epoxidation. NDH activity was measured as the rate of NADH oxida-
tion in the presence of 1 mM duroquinone and 125 M NADH. Ac-
tivities are expressed as a percentage of that of the 0 M DPI controls
(154 nmol min1 mg1 for pMMO and 930 nmol min1 mg1 for
NDH-2). Each data point is reported as the mean value  standard
deviation of three measurements.
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resulted in partial protection of pMMO activity from DPI
inhibition (i.e., 88% inhibition in the absence of PQ, relative to
50% inhibition in the presence of 100 M PQ) (Table 1).
According to our proposed electron transfer pathway (Fig.
1A) and the mechanism in Fig. 2, DPI is expected to inhibit
pMMO turnover by inactivating NDH-2, thereby disrupting
electron transfer from NADH to the monooxygenase. To fur-
ther elucidate the role of DPI in blocking the electron transfer
pathway (Fig. 1A), we examined its effect on hydroquinol-
dependent pMMO activity. For this experiment we used de-
tergent-solubilized pMMO, which is not active with NADH
alone (40), but is active with exogenous hydroquinols or with
NADH plus exogenous quinones and NDH-2 (13, 40).
As expected, the NADH-dependent activity of detergent-
soluble pMMO was very sensitive to DPI. Only 5 M DPI
was required to inhibit 50% of the activity (Fig. 5A), which was
similar to the amount required to inhibit membrane-bound
pMMO activity (Fig. 4). Unexpectedly, the pMMO activity
driven by exogenous decyl-plastoquinol (PQH2) was also in-
hibited by DPI (Fig. 5A). However, the PQH2-dependent
pMMO activity was markedly less sensitive to DPI than the
NADH-dependent activity. For example, 50% inhibition of the
PQH2-dependent activity required 70 M DPI, relative to
5 M DPI for the NADH-dependent activity (Fig. 5A).
To determine the effect of DPI on pMMO activity in whole
cells, we treated M. capsulatus cells with DPI in the presence of
formate, washed the cells thoroughly, then assayed pMMO
activity with either formate, formaldehyde, or duroquinol as
the electron donor. DPI did inhibit whole-cell pMMO activity
in a concentration-dependent manner (Fig. 5B). Furthermore,
the inhibition was independent of the electron donor; the same
extent of inhibition is observed with formate, formaldehyde,
and duroquinol (Fig. 5B). The concentration of DPI required
for 50% inhibition of whole-cell pMMO activity was similar to
that needed for inhibition of the hydroquinol-driven activity of
detergent-solubilized pMMO (Fig. 5) and much higher than
the concentration required to inhibit the NADH-dependent
activities of pMMO and NDH-2 in vitro. For example, 50%
inhibition of whole-cell pMMO activity required 70 M DPI
(Fig. 5B), whereas the NADH-dependent in vitro activities
required less than 5 M DPI to reach 50% inhibition (Fig. 4).
To determine if the effect of DPI on whole-cell pMMO
activity resulted from NDH-2 inhibition, we measured pMMO
activity in cells treated with 0, 50, or 500 M DPI, lysed the
cells, and isolated membrane fractions to measure NADH-
dependent NDH-2 and pMMO activities in vitro (Table 2).
Most (83%) of the whole-cell pMMO activity remained after
treatment with 50 M DPI, whereas only 27% of NDH-2
activity was recovered in the membrane fraction, relative to an
untreated control (Table 2). The percentage of NADH-driven
pMMO activity recovered in the membrane fraction (16%) was
comparable to the recovered NDH-2 activity (27%), rather
FIG. 5. DPI inhibition profiles of hydroquinol- and NADH-driven
pMMO activities in vitro (A) and hydroquinol- formaldehyde-, and
formate-driven pMMO activities in vivo (B). In A, the activity of
detergent-solubilized pMMO was measured in the presence of DPI
with 5 mM NADH plus 350 M PQ or 3 mM PQH2 as the reductant.
Activities are expressed as a percentage of the specific activity in the
absence of DPI (17.8 and 6.4 nmol min1 mg1 for NADH and
PQH2-driven controls, respectively). (B) M. capsulatus cells were in-
cubated for 5 min at 45°C with DPI and 5 mM formate, washed three
times, and assayed for pMMO activity with either 5 mM formate, 5
mM formaldehyde, or 2 mM duroquinol as the reductant. Activities
are expressed as a percentage of that of the 0 M DPI control (205.4,
225.1, and 130.8 nmol min1 mg1 for the formate-, formaldehyde-,
and duroquinol-driven controls, respectively). Each data point is re-
ported as the mean value  standard deviation of three or four mea-
surements.
TABLE 1. Effect of incubation time on DPI inhibition of pMMO
activity in membranes and protection by PQa
Incubation conditions
Mean pMMO sp act
(nmol min1 mg1)  SD
(% of control)
5 M DPI, 5 mM NADH for 0 min 11.9  3.4 (17.2)
5 M DPI, 5 mM NADH for 3 min 5.6  2.6 (8.1)
5 M DPI, 5 mM NADH for 6 min 3.9  0.8 (5.6)
5 M DPI, 5 mM NADH for 15 min 2.8  1.3 (4.0)
0 M DPI, 5 mM NADH for 0 min 69.1  4.1 (100)
0 M PQ, 5 M DPI 8.2  1.4 (11.7)
25 M PQ, 5 M DPI 22.1  2.8 (31.5)
50 M PQ, 5 M DPI 25.9  1.1 (37.0)
100 M PQ, 5 M DPI 34.7  3.6 (49.5)
0 M PQ, 0 M DPI 70.1  5.7 (100)
a M. capsulatus membranes were incubated at 45°C for the indicated time in
the presence of 5 mM NADH and 0 or 5 M DPI before initiating the assay with
propene. M. capsulatus membranes were incubated for 3 min at 45°C with DPI,
PQ, and 1 ml of propene before initiating the assay with NADH. Values repre-
sent the means of three or four measurements. Numbers in parentheses are the
activities expressed as a percentage of that of the 0 M DPI control.
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than the whole-cell pMMO activity (83%) (Table 2). Similar
trends were observed for whole cells treated with 500 M DPI;
28% of whole-cell pMMO activity remained, whereas only 4%
and 2% of NDH-2 and pMMO activity, respectively, remained
in the membrane fraction (Table 2).
To ensure that the effect of DPI on the membrane fraction
was not enhanced by cell lysis fostering access of adventitiously
bound DPI to its target sites, the cells were washed extensively
prior to lysis. In addition, a control sample was prepared by
incubating cells with 50 M DPI in the absence of formate.
The NDH-2 and pMMO activities in membranes from this
control were four- to fivefold greater than in the sample
treated with 50 M DPI and formate and only slightly lower
than that of the untreated control (Table 2). Thus, the differ-
ence between whole-cell and membrane activities is not due to
the presence of adventitious DPI during lysis.
DPI inhibition of AMO. DPI also inhibited NH3-dependent
oxygen uptake and ethylene oxidation catalyzed by AMO in
whole cells of N. europaea, with 50% inhibition observed at
100 M DPI (Fig. 6). In these experiments, N. europaea cells
were incubated with DPI and then washed thoroughly to re-
move unreacted DPI before enzyme activity was measured.
The extensive washing did not restore AMO activity (Fig. 6),
suggesting that the inhibition was irreversible. NH3-dependent
O2 uptake by AMO in cell-free lysates was completely inhib-
ited by 50 M DPI, but detailed characterization was pre-
vented by the instability of AMO in vitro.
As discussed above, ammonia oxidation in N. europaea is
dependent on HAO to supply reducing equivalents from the
oxidation of hydroxylamine (3). Hydroxylamine-dependent O2
uptake was unaffected by DPI (Fig. 6A), indicating that HAO
and the electron transfer pathway from HAO to the terminal
oxidase were not disrupted by DPI. DPI also inhibited both
hydrazine- and duroquinol-driven ethylene oxidation activities
of AMO in whole cells (Fig. 6B). Furthermore, nearly identical
inhibition profiles were observed for these two reductants, with
50% inhibition at 200 M DPI (Fig. 6B). This is similar to
the concentration required for 50% inhibition of ammonia-
dependent O2 uptake (Fig. 6A), as well as pMMO activity in
whole cells (70 M, Fig. 5B), and at least an order of mag-
nitude greater than required for inhibition of NADH-depen-
dent activities of NDH-2 and pMMO in membrane fractions
(less than 5 M, Fig. 4).
In view of the much broader substrate range of AMO rela-
tive to pMMO (24, 27, 29), we considered the possibility that
hydroxylation of DPI caused the inactivation of AMO, as is the
case for certain alkynes, cyclopropanes, and aniline derivatives
(30). Inactivation by these mechanism-based inhibitors re-
quires turnover of AMO and is thereby prevented by anaerobic
conditions or the presence of alternative substrates that com-
pete for the hydroxylation site of AMO (23, 26, 30). We there-
fore investigated whether the presence of hydrocarbon sub-
strates or removal of oxygen could similarly protect AMO from
DPI. Control samples were incubated in buffer alone, whereas
FIG. 6. Effect of DPI on HAO and AMO activities in whole cells of
N. europaea. Cells were incubated with DPI for 5 min at room tem-
perature, washed five times, and assayed for AMO and HAO activity.
(A) AMO activity was measured as the rate of oxygen uptake in the
presence of 3.75 mM NH4
 and is expressed as a percentage of the 0
M DPI control activity (1.05 mol min1 mg1). HAO activity was
measured after adding 0.6 mM allylthiourea to inhibit AMO, followed
by 1.25 mM NH2OH. Activity is expressed as a percentage of the 0 M
DPI control (256 nmol min1 mg1). (B) AMO activity of the DPI-
treated cells was measured as the rate of ethylene epoxidation with
either 500 M hydrazine or 500 M duroquinol as the reductant.
Activities are expressed as a percentage of the 0 M DPI control
sample (348 and 165 nmol min1 mg1 for the hydrazine-driven and
duroquinol-driven controls, respectively). Each data point is reported
as the mean value  standard deviation of four measurements.
TABLE 2. NDH-2 and pMMO activity after DPI treatment of M. capsulatus cellsa
Incubation conditions
Mean sp act (nmol min1 mg1)  SD (% of control)
Formate-dependent pMMO NADH-dependent pMMO NDH
0 M DPI, 5 mM formate 185.9  8.4 (100) 201.5  21.9 (100) 583.8  84.1 (100)
50 M DPI, 5 mM formate 154.3  27.1 (83) 32.4  3.2 (16.2) 158.1  48.7 (27.1)
500 M DPI, 5 mM formate 52.6  18.1 (28.3) 4.3  1.2 (2.1) 24.6  6.3 (4.2)
50 M DPI, no formate 155.6  12.7 (83.7) 152.3  11.0 (75.6) 517.7  34.3 (88.7)
a Cells were incubated for 10 min at 45°C under the conditions described and then washed three times with 50 mM PIPES (pH 7.2). A portion of each sample was
saved for in vivo pMMO assays, and the remainder was lysed and the membranes were isolated and assayed for in vitro NADH-driven pMMO and NDH activities.
Values reported are the mean of 8 to 14 measurements. Numbers in parentheses are the activities expressed as a percentage of that of the 0 M DPI control.
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experimental samples included either DPI or DPI plus the
hydrocarbon substrate. All samples were washed extensively
prior to measuring ethylene oxidation activity of AMO.
The AMO substrates methane, ethylene, toluene, and phe-
nol had no protective effect; nearly identical levels of AMO
activity were recovered after incubation with DPI regardless of
the presence of these hydrocarbons (Table 3). Incubation of N.
europaea cells with DPI under anaerobic conditions also failed
to protect AMO from inhibition. In fact, removal of oxygen
resulted in recovery of 50% less AMO activity relative to
incubation in the presence of oxygen (Table 3). The increased
sensitivity to DPI under anaerobic conditions could be due to
enhanced reduction of the DPI binding site without O2 to serve
as the terminal electron acceptor. This explanation is consis-
tent with similar enhancement of DPI inhibition observed in
the presence of the electron donor hydrazine (Table 3), sug-
gesting that reduction is a precursor to DPI binding, as ex-
pected from its proposed mechanism of inactivation (Fig. 2).
The only agent found to protect AMO from DPI inhibition
was allylthiourea, which inhibits AMO by chelating copper
(21). A similar chelator, thiourea, is known to protect AMO
from mechanism-based inactivation by alkynes, anilines, and
cyclopropanes (30). We found that 90% of AMO activity was
recovered after incubation with 200 M DPI in the presence of
1 mM allylthiourea, whereas only 48% remained after DPI
treatment in the absence of allylthiourea (Table 3). In this
experiment, two control samples were prepared, with no allyl-
thiourea and no DPI or with 1 mM allylthiourea and no DPI.
The experimental samples contained no allylthiourea and 200
M DPI or 1 mM allylthiourea and 200 M DPI. The activities
reported in Table 3 for samples with DPI alone are relative to
the control with no DPI or allylthiourea. Similarly, the activi-
ties of the samples incubated with both allylthiourea and DPI
are reported relative to the control treated with allylthiourea
alone (Table 3). The buffer used to wash these samples con-
tained 50 M CuSO4 to reconstitute AMO activity lost due to
copper chelation by allylthiourea. In this way we determined
that the loss of activity due to incubation with allylthiourea
alone is almost fully reversible. The allylthiourea-treated sam-
ple retained 93% of the AMO activity in an untreated control.
DISCUSSION
Inactivation of NDH-2 by DPI and its effect on pMMO ac-
tivity. The substrate oxidation mechanism of pMMO and
AMO remains poorly characterized due to their low and un-
stable activity in vitro (27, 31, 51). The lack of robust activity
in vitro may arise from the use of nonphysiological reducing
agents that are unable to efficiently reduce the monooxygen-
ases. Hence, a better understanding of the physiological mech-
anism for reduction of pMMO and AMO may lead to increased
stability and activity in vitro and facilitate characterization of
these novel enzymes.
In previous publications we proposed the electron transfer
pathway to pMMO that is illustrated by the solid lines in Fig.
1A. This proposal was based on the observation that pMMO
activity could be driven by either exogenous hydroquinols or
exogenous quinones plus NADH and NDH-2 under conditions
in vitro where NADH alone is ineffective as a reductant (13,
40). This proposal could be tested by determining if inhibition
of NDH-2 prevents turnover of pMMO. However, there are no
general inhibitors of NDH-2 enzymes; flavone inhibits some
NDH-2 enzymes but is ineffective against the NDH-2 from
M. capsulatus (13).
In the present study we demonstrated that DPI is a potent,
irreversible inhibitor of purified M. capsulatus NDH-2: 97%
inhibition was observed in the presence of 10 M DPI (Fig. 3,
inset). DPI also irreversibly inhibited NDH-2 activity in iso-
lated membrane fractions. This inhibition required reduction
of NDH-2, since DPI had little effect on enzyme activity in the
absence of NADH (Fig. 3). Thus, inhibition of NDH-2 by DPI
has the characteristics one would expect from its typical mech-
anism of action on flavoproteins (Fig. 2) (10, 35, 43), in that
inhibition was irreversible and required reduction by NADH
(Fig. 3 and 4). We conclude that DPI reacts only with the
reduced form of NDH-2, resulting in covalent modification of
its flavin cofactor and inactivation of its normal redox cycle.
Having shown that DPI will inactivate NDH-2, we investi-
gated whether NADH-coupled pMMO activity is also inhib-
ited by DPI. We found that titration of membrane fractions
with DPI in the presence of NADH resulted in similar inhibi-
tion profiles for NADH-dependent pMMO and NDH-2 activ-
ities (Fig. 4). Furthermore, the inhibitory effect of DPI on
pMMO activity was irreversible and dependent on the pres-
ence of NADH, consistent with inactivation of NDH-2 as the
cause of pMMO inhibition. Protection of pMMO activity by
PQ (Table 1) is also consistent with inhibition caused by inac-
tivation of NDH-2. PQ is an efficient electron acceptor for
NDH-2 (13), so increased concentrations of PQ would de-
crease the steady-state concentration of reduced NDH-2, pro-
viding less opportunity for reaction with DPI and therefore less
disruption of electron flow to pMMO. A similar result was
observed for DPI inhibition of cytochrome P450 reductase
(43), whereby increased concentrations of the electron accep-
tor (cytochrome c) resulted in decreased sensitivity to DPI. We
therefore conclude that electron transfer from NADH to
pMMO in vitro requires NDH-2 and that DPI inhibits pMMO
by blocking this pathway (Fig. 1A).
DPI inhibition of pMMO and AMO that is independent of
NDH-2. We have proposed that NADH, NDH-2, and the qui-
none pool convey reducing equivalents from formaldehyde and
TABLE 3. Protection of AMO by allylthiourea but not by




(% of control)  SD
Mean AMO activity
with DPI and protectant
(% of control)  SD
Allylthiorrea (1 mM) 47.6  5.7 90.4  6.8
Methane (3 ml) 27.0  8.4 22.1  7.4
Ethane (3 ml) 27.2  6.2 23.2  5.1
Phenol (1 mM) 23.3  3.9 26.5  4.9
Toluene (1 mM) 32.9  5 26.7  6.6
Anaerobic 36.8  7.1 19.2  9.3
Hydrazineb (500 M) 77.4  5.9 43.3  4.8
a For each protectant, three samples of N. europaea cells were prepared: one
with 200 M DPI, one with 200 M DPI and the indicated protectant, and a
control with no DPI and no protectant. These samples were incubated at room
temperature for 5 min, washed four times with 50 mM phosphate (pH 8), and
assayed for AMO activity by measuring the rate of ethylene oxidation as de-
scribed in the text. Activities are given relative to the activity of the control
sample and represent the mean of three measurements.
b These samples contained 100 M DPI rather than 200 M as in all the other
samples.
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formate to pMMO in vivo (solid lines in Fig. 1A) (13, 40). On
this basis, we expected DPI to inhibit formate- or formalde-
hyde-driven pMMO activity in whole cells at a concentration
similar to that observed for inhibition of NADH-driven activity
in vitro (10 M). We found that formate- and formaldehyde-
driven pMMO activities were both inhibited by DPI (and with
identical sensitivity), but these activities were less sensitive
than NADH-driven in vitro activity by at least an order of
magnitude (cf. Fig. 4 and 5B). The obstacle of crossing the cell
membrane might account for some of the reduced sensitivity of
pMMO in whole cells to DPI. However, treatment of whole
cells with 50 M DPI caused inactivation of 73% of the
NDH-2 activity but only 17% of the pMMO activity (Table 2),
indicating that DPI can readily interact with and substantially
inhibit NDH-2 in whole cells without significantly affecting
pMMO activity.
It is possible that the turnover rate of NDH-2 is much
greater than that of pMMO in vivo, such that NDH-2 activity
remaining after DPI treatment was sufficient to support the
relatively high level of whole-cell pMMO activity observed
(Table 2). However, if the residual NDH-2 activity is sufficient
to support significant pMMO activity in vivo, it should support
similar levels of pMMO activity in vitro. In fact, the NADH-
driven pMMO activity recovered from DPI-treated cells was
5-fold lower than pMMO activity in vivo (Table 2). Further-
more, the percentage of NADH-driven pMMO activity was
comparable to the percentage of recovered NDH-2 activity
rather than the whole-cell pMMO activity (Table 2). Thus, it
appears that electron transfer from formate to pMMO can
substantially continue in the presence of DPI concentrations
sufficient to inactivate NDH-2. This result suggests the exis-
tence of an additional electron transfer pathway from formate
to pMMO that is independent of NDH-2 but also contains a
DPI-sensitive redox site (dashed lines in Fig. 1A). This second
DPI-binding site has a lower affinity for the inhibitor than
NDH-2, since 15-fold more DPI is required to inhibit for-
mate-driven pMMO activity relative to NDH-2 activity (Fig.
5B and Table 2).
The redox cofactors and proteins that constitute this addi-
tional electron transfer pathway from formate to pMMO re-
main unknown at present. Both pathways illustrated in Fig. 1A
appear to operate simultaneously in vivo, since treatment of
whole cells with formate and DPI results in inhibition of NDH-
2-dependent as well as NDH-2-independent pathways (Table
2). The NDH-2-independent pathway could consist of a single
DPI-sensitive protein that transfers electrons from formate
directly to pMMO. A pyrroloquinoline quinone (PQQ)-con-
taining formaldehyde dehydrogenase was recently isolated
from M. capsulatus membranes that appears to transfer reduc-
ing equivalents specifically from formaldehyde to the cyto-
chrome bc1 complex (50). It was suggested that the reduced
cytochrome bc1 complex subsequently transfers these reducing
equivalents to pMMO (50). This proposed electron transfer
chain could be responsible for the NDH-2 independent DPI
inhibition of pMMO, since both PQQ and low-potential b-
hemes are reportedly sensitive to DPI (6, 16). However, the
response of whole-cell pMMO activity to DPI was independent
of the source of reducing equivalents (Fig. 5B), suggesting that
a single DPI-binding site blocks electron transfer to pMMO
from formate, formaldehyde, and duroquinol, and that this site
is located downstream of the quinone pool. The PQQ-contain-
ing dehydrogenase is not likely to be the DPI-binding site,
since it is specific for formaldehyde (50) and therefore could
not be responsible for inhibition of formate- or duroquinol-
driven pMMO activity. Similarly, binding of DPI to the cyto-
chrome bc1 complex could account for inhibition of pMMO
only if it mediates electron transfer from formate, formalde-
hyde, and duroquinol. This seems unlikely, since several labo-
ratories have reported that duroquinol supports the activity of
pure pMMO in the absence of any cytochrome bc1 (4, 11, 31,
51).
It was recently reported that maximal activity of purified
pMMO was observed with NADH, NDH-2, and duroquinol
(11), suggesting that no other proteins are required to mediate
electron transfer from hydroquinols to pMMO. Consistent
with this proposal is DPI inhibition of the PQH2-driven activity
of detergent-solubilized pMMO (Fig. 5A). Significantly, the
PQH2-driven activity is 15-fold less sensitive to DPI than the
NADH-driven activity (Fig. 5). Given their similar response to
DPI, we propose that a single DPI-binding site is responsible
for inhibiting formaldehyde-, formate-, and duroquinol-driven
pMMO activity in vivo as well as plastoquinol-driven activity in
vitro. This implies that the NDH-2-independent pathway in-
cludes the quinone pool and that binding of DPI to this rela-
tively low-affinity site blocks electron transfer from hydroquin-
ols to pMMO (Fig. 1A), perhaps within the pMMO complex
itself (see below). In contrast, NDH-2 activity is essential for
NADH-driven pMMO activity, and the relatively greater sen-
sitivity of this activity is due to the high affinity of NDH-2 for
DPI (Fig. 3).
DPI also inhibited AMO activity in cells of N. europaea (Fig.
6). This inhibition appeared to be irreversible, since extensive
washing of the cells after incubation with DPI did not restore
activity. Mechanism-based inhibition resulting from hydroxy-
lation of DPI at the AMO active site does not appear to be
responsible for the effect of DPI on AMO activity (Table 3). In
addition, it is unlikely that inactivation of an NDH-2 enzyme by
DPI is responsible for inhibition of AMO activity, since the
electron transfer pathway from HAO to AMO in N. europaea
is thought to be independent of NADH (the redox potential of
the NH2OH/NO2
 couple is 300 mV higher than that of
NADH/NAD) (8, 48). However, it is possible that an enzyme
similar to NDH-2 mediates reduction of the quinone pool (and
ultimately AMO) in N. europaea, with an electron donor other
than NADH (a reduced cytochrome, for example). A search of
the N. europaea genome revealed a single gene with sequence
homology (26% identity, 41% similarity) to the NDH-2 of
Escherichia coli (7), but a knockout mutation of this gene had
no effect on AMO activity or inhibition by DPI (data not
shown). We propose instead that DPI disrupts electron trans-
fer from the quinone pool to AMO in a manner analogous to
that suggested above for the NDH-2-independent inhibition of
pMMO (Fig. 1B).
DPI appears to specifically inhibit AMO activity, having no
effect on hydroxylamine-dependent oxygen uptake by N. euro-
paea cells (Fig. 6A). Therefore, neither HAO turnover nor the
electron transfer pathway from HAO to the terminal oxidase is
affected by DPI. If we assume that the quinone pool is a
common source of reducing equivalents for both AMO and the
terminal oxidase (as suggested by Hooper and coworkers [48]
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and illustrated in Fig. 1B), then the specificity of DPI inhibition
of AMO is consistent with disruption of electron flow from
reduced quinones to the monooxygenase. Furthermore, iden-
tical levels of AMO inhibition by DPI were observed with
either hydrazine or duroquinol as the reductant (Fig. 6B).
HAO and the quinone pool are intermediates when hydrazine
donates electrons to AMO and the terminal oxidase (3), where-
as duroquinol is thought to directly reduce AMO (or perhaps
the endogenous quinone pool) (39, 48). DPI could disrupt
electron transfer to AMO from hydrazine and duroquinol by
reacting with redox components unique to each reductant.
However, the identical sensitivity to DPI is consistent with
disruption of electron flow at a point common to both reduc-
tants, i.e., between the quinone pool and AMO (Fig. 1B).
The precise identity of the DPI- binding site in N. europaea
(and by analogy the low-affinity DPI-binding site in M. capsu-
latus) remains unknown. However, if hydroquinols react direct-
ly with AMO and pMMO, as has been proposed (13, 40, 48),
then DPI must inhibit electron transfer between the hydro-
quinol-binding site and the hydroxylation site, i.e., within
the monooxygenase itself. Although there is no evidence for
a flavin-binding site in either AMO or pMMO, DPI has been
reported to react with redox cofactors other than flavins (6,
16). Protection of AMO by the copper chelator allylthiourea
(Table 3) could be significant in this regard. Specific chelation
of copper has long been known to completely inhibit AMO (5,
21) and pMMO (14, 42) in whole cells and membrane frac-
tions, but the precise role and location of the labile copper was
unknown. More recently, several laboratories have reported
that purified pMMO is also inhibited by chelation of copper (4,
31, 51), suggesting that this labile copper is an obligatory co-
factor of the catalytic complex of pMMO and, by homology,
AMO as well. Since removal of this labile copper protects
AMO from inhibition by DPI, we tentatively suggest that it is
required for electron transfer from the physiological electron
donor (presumably hydroquinol) to the hydroxylation site. Fu-
ture investigations into the mechanism of DPI inhibition of
AMO and pMMO could provide significant information re-
garding the redox chemistry of these novel monooxygenases.
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